Life Science

Description : 4(3H)-Quinazolinone, 2-(2-hydroxyphenyl)- serves as a critical heterocycle-derived intermediate with extensive utility in medicinal chemistry, particularly in the development of targeted anticancer, antiviral, and antimicrobial therapeutic platforms due to its versatile core scaffold and hydrogen-bonding capabilities. Market dynamics indicate an accelerating demand within the global CDMO and custom synthesis sectors for high-purity 2-(2-hydroxyphenyl)-4(3H)-quinazolinone, driven by its application as a key building block in complex small-molecule drug discovery and structure-activity relationship (SAR) studies. Advanced synthetic pathways utilizing one-pot condensation strategies of anthranilamide derivatives or isatoic anhydride under green catalytic conditions have increasingly enhanced regulatory compliance and process scalability for commercial manufacturing. We are an globally established '4(3H)-Quinazolinone, 2-(2-hydroxyphenyl)-' intermediates supplier with >= 99% purity, ensuring minimal carry-over of impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting (4(3H)-Quinazolinone, 2-(2-hydroxyphenyl)- COA/TDS/SDS region-specific regulatory support. Beyond supply, we support partners through the entire product lifecycle from route scouting, process and formulation development, and analytical method development to scale-up, process optimisation, and pilot-to-commercial manufacturing. Our teams also assist with GMP-compliant quality assurance, regulatory documentation, and global supply chain and logistics coordination.

Description : 2,4-Difluorobenzylamine (CAS No: 72235-52-0) serves as a critical fluorinated building block within the global speciality chemical landscape, primarily utilised as an indispensable intermediate in the synthesis of active pharmaceutical ingredients (APIs), most notably antiretroviral integrase inhibitors such as Dolutegravir and Cabotegravir. The strategic placement of difluoro substituents on the aromatic ring imparts superior lipophilicity, metabolic stability, and binding affinity to target drug candidates, driving high-purity demand across contract development and manufacturing organisations (CDMOs). Beyond its core antiretroviral footprint, this versatile nucleophilic amine is increasingly deployed in the development of advanced agrochemical formulations, including targeted herbicides and insecticides, as well as high-performance speciality polymers requiring enhanced thermal and chemical resistance. We are an globally established 2,4-Difluorobenzylamine intermediates supplier with >= 99% purity, ensuring minimal carry-over of impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting 2,4-Difluorobenzylamine COA/TDS/SDS region-specific regulatory support. Beyond supply, we support partners through the entire product lifecycle from route scouting, process and formulation development, and analytical method development to scale-up, process optimisation, and pilot-to-commercial manufacturing. Our teams also assist with GMP-compliant quality assurance, regulatory documentation, and global supply chain and logistics coordination.

Description : Alumino Silicates (Aluminum Silicate) (Hydrous: 1332-58-7, Calcined: 92704-41-1) represent a versatile class of minerals that serve as the backbone for both high-end industrial engineering and critical pharmaceutical formulations. While Hydrous Alumino Silicate (Kaolin) is core in the pharmaceutical sector for its exceptional adsorption capacity and chemical inertness, its thermally treated counterpart, Calcined Alumino Silicate, is a staple in metallurgy and material science due to its enhanced opacity, hardness, and electrical resistivity. The calcination process - heating the mineral between 650°C and 900°C - removes structural water to create an anhydrous, amorphous structure that optimises light scattering in coatings and reinforces polymer matrices. In contrast, pharmaceutical-grade hydrous silicates are purified to rigorous pharmacopoeia standards to act as intestinal adsorbents or high-functionality excipients. By connecting through heavy industrial performance and life-science purity, aluminosilicates offer a multi-functional solution for speciality chemical suppliers and paint manufacturers. We are a globally established unified CDMO worldwide, with comprehensive regulatory documentation (CoA), traceability, and consistent global supply capabilities, ensuring reliable lead times and quality assurance across all grades.